Oncogenic magnesium transporter 1 upregulates programmed death-1-ligand 1 expression and contributes to growth and radioresistance of glioma cells through the ERK/MAPK signaling pathway

Radiotherapy has been established as a major therapeutic modality for glioma, whereas new therapeutic targets are needed to prevent tumor recurrence. This study intends to explore the regulatory role of magnesium transporter 1 (MAGT1) in radiotherapy resistance of glioma through modulating ERK and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuanyuan, Wang, Hongbing, Wei, Dongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161830/
https://www.ncbi.nlm.nih.gov/pubmed/35416125
http://dx.doi.org/10.1080/21655979.2022.2037214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161830/
https://www.ncbi.nlm.nih.gov/pubmed/35416125
http://dx.doi.org/10.1080/21655979.2022.2037214

Ejemplares similares